Login / Signup
Evan L Fogel
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 4
Top Topics
Phase Iii
Clinical Trial
Oxidative Stress
Open Label
Top Venues
JMIR research protocols
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Evan L Fogel
,
Jeffrey J Easler
,
Ying Yuan
,
Dhiraj Yadav
,
Darwin L Conwell
,
Santhi Swaroop Vege
,
Samuel Y Han
,
Walter G Park
,
Vanessa Patrick
,
Fletcher A White
Safety, Tolerability, and Dose-Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis: Protocol for a Phase 1 Clinical Trial to Determine Safety and Identify Side Effects.
JMIR research protocols
13 (2024)
Evan L Fogel
,
Jeffrey J Easler
,
Ying Yuan
,
Dhiraj Yadav
,
Darwin L Conwell
,
Santhi Swaroop Vege
,
Samuel Y Han
,
Walter G Park
,
Vanessa Patrick
,
Fletcher A White
Safety, Tolerability, and Dose-Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis: Protocol for a Phase 1 Clinical Trial to Determine Safety and Identify Side Effects.
JMIR research protocols
13 (2024)
Evan L Fogel
,
Jeffrey J Easler
,
Ying Yuan
,
Dhiraj Yadav
,
Darwin L Conwell
,
Santhi Swaroop Vege
,
Samuel Y Han
,
Walter G Park
,
Vanessa Patrick
,
Fletcher A White
Safety, Tolerability, and Dose-Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis: Protocol for a Phase 1 Clinical Trial to Determine Safety and Identify Side Effects.
JMIR research protocols
13 (2024)
Evan L Fogel
,
Jeffrey J Easler
,
Ying Yuan
,
Dhiraj Yadav
,
Darwin L Conwell
,
Santhi Swaroop Vege
,
Samuel Y Han
,
Walter G Park
,
Vanessa Patrick
,
Fletcher A White
Safety, Tolerability, and Dose-Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis: Protocol for a Phase 1 Clinical Trial to Determine Safety and Identify Side Effects.
JMIR research protocols
13 (2024)